Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0002111813-26-000009

President and CEO acquired 761,428 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Parikh Anand Kiran President and CEO 2026-06-15 Conversion +761,428 761,428 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Parikh Anand Kiran President and CEO 2026-06-15 Conversion · Series B Preferred Stock −761.43 0 D: show line 2 in the form
Loading xslF345X06/form4-06162026_080634.xml…